Gaudium IVF & Women Health Limited has announced a significant corporate milestone with the formal update of its Corporate Identification Number following its recent stock exchange listing. The company communicated this development to both major Indian stock exchanges on April 15, 2026.

Corporate Identification Number Update

The company's CIN has been officially changed from 'U85100DL2015PLC278296' to 'L85100DL2015PLC278296', reflecting its transition from unlisted to listed status. This change occurred pursuant to the listing of the company's equity shares on both the National Stock Exchange of India Limited and BSE Limited.

Company Profile and Financial Structure

Gaudium IVF and Women Health Limited, formerly known as Gaudium IVF and Women Health Private Limited, was incorporated on March 24, 2015. The company operates under the jurisdiction of ROC Delhi II and maintains its registered address at B1/51, Janak Puri, Janakpuri B-1, West Delhi, New Delhi.

The company maintains active compliance status and held its last Annual General Meeting on September 27, 2025. Its balance sheet date is March 31, 2025.

Leadership and Governance Structure

The company's board comprises both promoter and independent directors, ensuring balanced corporate governance. The promoter directors include Manika Khanna as Managing Director and Peeyush Khanna as Whole-time Director, both appointed since the company's incorporation.

The independent directors include Rajesh Chunilal Bhojani, Suresh Marpu, and Brajesh Singh Bhadauria. The company's key management personnel include Naveen Kumar as Company Secretary and Compliance Officer, and Rakesh Kumar Sharma as Chief Financial Officer.

Banking Relationships and Charges

The company maintains banking relationships with major financial institutions. The Ministry of Corporate Affairs records show charges with ICICI Bank Limited for ₹27,99,70,000 that was satisfied on October 9, 2025, and an ongoing charge with HDFC Bank Limited for ₹7,50,00,000 created on November 16, 2024.

This CIN update represents a formal recognition of the company's successful transition to public listing status, marking an important milestone in its corporate journey from a private limited company to a publicly listed entity on India's premier stock exchanges.

Gaudium ivf & women health Limited has filed its quarterly compliance certificate with stock exchanges for the quarter ended March 31, 2026, in accordance with SEBI regulatory requirements. The company submitted the mandatory documentation under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018.

Regulatory Compliance Filing

The compliance certificate was submitted to both major Indian stock exchanges on April 10, 2026. Company Secretary and Compliance Officer Naveen Kumar, with membership number A69788, signed the filing on behalf of the company. The submission was made to BSE Limited and the National Stock Exchange of India Limited as part of the company's regular quarterly compliance obligations.

Registrar Confirmation

Bigshare Services Private Limited, serving as the company's registrar and transfer agent, issued a confirmation certificate dated April 9, 2026. The registrar confirmed that Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 is not applicable to Gaudium IVF and Women Health Limited for the quarter ended March 31, 2026.

Share Dematerialization Status

According to the registrar's certificate, the non-applicability of the regulation stems from the company's complete share dematerialization status. Key findings include:

• All company shares are held in dematerialized form
• No requests for rematerialization were received during the quarter
• No requests for dematerialization were received during the quarter
• The entire shareholding remains in electronic format

Corporate Information

The company, formerly known as Gaudium IVF and Women Health Private Limited, operates from its registered office at B1/51, Janak Puri, Janakpuri B-1, West Delhi, New Delhi. The filing represents part of the company's ongoing commitment to maintaining regulatory compliance with SEBI requirements for listed entities.

The submission of this compliance certificate demonstrates the company's adherence to depositories and participants regulations, ensuring transparency in share transfer and holding mechanisms for the quarter ended March 31, 2026.